This first edition report provides a comprehensive overview of the global Real-World Data & Evidence (RWD/E) market from 2025 to 2030. The market is defined as revenue generated from the generation, aggregation, and analysis of real-world data by biopharma, CROs, and other stakeholders. The ecosystem encompasses a diverse set of players spanning data generators, aggregators, and enablers, with vendor selection driven by data type, quality, access model, and analytic sophistication.
This report is informed by 35 in-depth primary stakeholder interviews and extensive secondary research. The market model employs a bottoms-up approach based on average RWD spend of key customer groups (e.g., large and small biopharma, and CROs). The market is segmented by product type, use case, therapeutic area, and data type.
See more details below.